A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: Possible implication for the treatment of glaucoma

British Journal of Ophthalmology

Volumn 85, Issue 10, 2001, Pages 1252-1259

  Osborne, N N ^a   Melena, J ^a   Chidlow, G ^a   Wood, J P M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLION; GLAUCOMA; HUMAN; HYPOTHESIS; HYPOXIA; NERVE CELL NECROSIS; NEUROOPHTHALMOLOGY; NEUROPATHOLOGY; OPTIC NERVE INJURY; PRIORITY JOURNAL; REVIEW;

ALGORITHMS; ANIMALS; ANOXIA; CELL DEATH; GANGLIA, SENSORY; GLAUCOMA; HUMANS; ISCHEMIA; OPTIC DISK; RATS;

EID: 0034809474     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.85.10.1252     Document Type: Review

References (124)

1. New definitions of glaucoma
2. Neuronal death in glaucoma
3. Chronic ocular hypertension following episcleral venous occlusion in rats
4. A rat model of chronic pressure-induced optic nerve damage
5. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma
6. Neuroprotection in relation to retinal ischemia and relevance to glaucoma
7. The patterns of retinal ganglion cell death in hypertensive eyes
8. Chronology of optic nerve head and retinal responses to elevated intraocular pressure
9. Programmed cell death of retinal ganglion cells during experimental glaucoma
10. Retinal ganglion cell death in glaucoma: The how, the why, and the maybe
11. Optic nerve head structure in glaucoma: Astrocytes as mediators of axonal damage
12. The role of age and cardiovascular disease in glaucomatous optic neuropathy
13. Vascular risk factors in glaucoma
14. Glaucoma risk factors observed in the Baltimore Eye Survey
15. Abnormalities of microcirculation in glaucoma: Facts and hints
16. Vascular risk factors for primary open angle glaucoma: The Egna-Neumarkt Study
17. Pathogenetic mechanisms of glaucoma not related to intraocular pressure
18. Prevalence of glaucoma. The Beaver Dam Eye Study
19. A population-based evaluation of glaucoma screening: The Baltimore Eye Survey
20. Intraocular pressure and glaucoma
21. Chronic glaucoma: Definition of the phenotype
22. Optic nerve blood-flow abnormalities in glaucoma
23. Optic nerve and choroidal circulation in glaucoma
24. A comparison of ocular blood flow in untreated primary open-angle glaucoma and ocular hypertension
25. Vascular pathogenesis of normal-tension glaucoma: A possible pathogenetic factor, other than intraocular pressure, of glaucomatous optic neuropathy
26. Blood supply of the optic nerve head: A "reality check"
27. Correlation between peripapillary atrophy and optic nerve damage in normal-tension glaucoma
28. Peripapillary fluorescein angiographic findings in primary open angle glaucoma
29. Peripapillary retinal blood flow in normal tension glaucoma
30. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders
31. Factors influencing blood flow in the optic nerve head
32. Inter-individual variation in blood supply of the optic nerve head. Its importance in various ischemic disorders of the optic nerve head, and glaucoma, low-tension glaucoma and allied disorders
33. Effects of raised intraocular pressure on retinal, prelaminar, laminar, and retrolaminar optic nerve blood flow in monkeys
34. Ocular perfusion pressure and choroidal blood flow in the rabbit
35. Introductory comments on blood flow autoregulation in the optic nerve head and vascular risk factors in glaucoma
36. Physiology of perfusion as it relates to the optic nerve head
37. Glaucoma patients demonstrate faulty autoregulation of ocular blood flow during posture change
38. Glaucoma and vasospasm
39. Patterns of early visual field loss in open-angle glaucoma
40. The onset and evolution of glaucomatous visual field defects
41. Pattern of glaucomatous neuroretinal rim loss
42. Retinal ganglion cell loss is size dependent in experimental glaucoma
43. Ganglion cell death in glaucoma: What do we really know?
44. The optic nerve head in glaucomatous optic neuropathy
45. Elastosis of the lamina cribrosa in glaucomatous optic neuropathy
46. Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma
47. The optic nerve head in glaucoma: Role of astrocytes in tissue remodeling
48. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss
49. An evaluation of optic disc and nerve fiber layer examinations in monitoring progression of early glaucoma damage
50. The mode of progressive disc cupping in ocular hypertension and glaucoma
51. The nerve fiber layer in the diagnosis of glaucoma
52. Optic disc parameters and onset of glaucomatous field loss. I. Methods and progressive changes in disc morphology
53. White matter ischaemia
54. Astrocyte energetics, function, and death under conditions of incomplete ischemia: A mechanism of glial death in the penumbra
55. Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head
56. Increased production of tumor necrosis factor-α by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells
57. Imaging extracellular waves of glutamate during calcium signaling in cultured astrocytes
58. Expression of nitric oxide synthase-2 (NOS-2) in reactive astrocytes of the human glaucomatous optic nerve head
59. Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2
60. Reactive astrocytes: Cellular and molecular cues to biological function
61. Atypical neural messengers
62. Quantitative analysis of optic disc cupping in compressive optic neuropathy
63. The prevalence of cupping in end-stage arteritic and nonarteritic anterior ischemic optic neuropathy
64. Optic disc cupping in arteritic anterior ischemic optic neuropathy
65. Optic disk cupping and electrocardiographic abnormalities in an American pedigree with Leber's hereditary optic neuropathy
66. Pathogenesis of cupping of the optic disc
67. Spreading depression as a contributor to ischemic brain damage
68. Propagation of intercellular calcium waves in retinal astrocytes and Muller cells
69. Perspectives on spreading depression
70. Spreading depression of activity in the cerebral cortex
71. The triggering of spreading depression in the chicken retina: A pharmacological study
72. Two mechanisms for spreading depression in the chicken retina
73. Spreading depression determines acute cellular damage in the hippocampal slice during oxygen/glucose deprivation
74. Metabolic and hemodynamic activation of postischemic rat brain by cortical spreading depression
75. Reactive microgliosis
76. Histochemical localisation of mitochondrial enzyme activity in human optic nerve and retina
77. On the nature of aging
78. The Muller cell: A functional element of the retina
79. Amino acid neurochemistry of the vertebrate retina
80. A one-hit model of cell death in inherited neuronal degenerations
81. The a-wave of the dark adapted electroretinogram in glaucomas: Are photoreceptors affected?
82. The b-wave of the dark adapted flash electroretinogram in patients with advanced asymmetrical glaucoma and normal subjects
83. The effect of age on human cone and rod ganzfeld electroretinograms
84. Cell types using glutamate as a neurotransmitter in the vertebrate retina
85. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma
86. Glutamine immunoreactivity in Muller cells of monkey eyes with experimental glaucoma
87. Up-regulation of glial fibrillary acidic protein in the retina of primate eyes with experimental glaucoma
88. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology
89. Glutamate receptors and circuits in the vertebrate retina
90. Actions of GABAergic ligands on brisk ganglion cells in the cat retina
91. GABA-activated whole-cell currents in isolated retinal ganglion cells
92. Estimating the contributions of NMDA and non-NMDA currents to EPSPs in retinal ganglion cells
93. Optical recordings of the effects of cholinergic ligands on neurons in the ganglion cell layer of mammalian retina
94. Endogenous adenosine and adenosine receptors localized to ganglion cells of the retina
95. Determination of the presence of alpha 2 adrenergic receptor subtypes in the rat retina
96. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma
97. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures
98. Vasoprotection as neuroprotection for the optic nerve
99. Expectations in the treatment of retinal diseases: Neuroprotection
100. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats
101. Ameliorative effect of MK-801 on retinal ischemia
102. Necrosis and apoptosis after retinal ischemia: Involvement of NMDA-mediated excitotoxicity and p53
103. Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia
104. 2+mediated injury in myelinated CNS axons
105. 2+ exchanger
106. Ions, channels, and transporters involved in anoxic injury of central nervous system white matter
107. + channels: Comparison with other β-adrenoceptor antagonists
108. 2+ channels
109. Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina
110. Topically applied betaxolol attenuates ischaemia-induced effects to the rat retina and stimulates BDNF mRNA
111. Memantine reduces alterations to the mammalian retina, in situ, induced by ischemia
112. Effects of dextromethorphan on ischemia induced electroretinogram changes in rabbit
113. Mannitol, dextromethorphan, and catalase minimize ischemic damage to retinal pigment epithelium and retina
114. Involvement of adenosine in retinal ischemia. Studies on the rat
115. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration
116. An investigation into the potential mechanisms underlying the neuroprotective effect of clonidine in the retina
117. Effect of the calcium antagonist, nifedipine, on ischemic retinal dysfunction
118. 2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina
119. Ocular ischemia and the effects of allopurinol on functional recovery in the retina of the arterially perfused cat eye
120. Enhancement of retinal recovery by conjugated deferoxamine after ischemia-reperfusion
121. Protection of the transiently ischemic cat retina by zinc-desferrioxamine
122. Gallium-desferrioxamine protects the cat retina against injury after ischemia and reperfusion
123. An immunohistochemical study of neuronal and glial cell interactions in retinae of rats with experimental glaucoma